Last week for #earlybird registration to attend #EMN2024! Don’t miss this opportunity to come to beautiful #Torino and meet #multiplemyeloma experts from all over the world. emn2024.com

Only few days left to the start of #EMN2024 conference! We look forward to seeing you in #Torino – Italy – 18-20 April, Lingotto Conference Center: emn2024.com

#EMN2024 has just started in #Torino – Italy! emn2024.com

First day of #EMN2024 has just ended. Tomorrow, many other interesting presentations, and don’t miss our session on Breakthrough trials changing clinical practice!

Second day of #EMN2024! We can’t wait for today's session with Harmony Alliance on data-driven research in multiple myeloma! HARMONY Alliance Foundation

End of second day of #EMN2024. Tomorrow an engaging & interactive session on Innovation and Challenges in #multiplemyeloma.

Last day of #EMN2024! Coming up, our EHA-EMN session on how to choose new treatment options European Hematology Association And a very interesting session with patients’ associations. Don’t miss it! International Myeloma Foundation Myeloma Patients Europe

Thanks to the scientific organizers, all the speakers and the participants of #EMN2024 in #Torino! Interactive and informative presentations, a unique opportunity for everyone! See you next year for #EMN2025 in Athens!

Joshua Richter, MD, FACP Jens Hillengass Myeloma Society Happy to see Jens Hillengass present our EMN EMN19 study results

📢Exciting news! The dates of the #EMN2025 conference in Athens have been confirmed: 10-12 April 2025. Check out the official website for all the latest updates: emn2025.com

🚨Abstract submissions to #EMN2025 in Athens are now OPEN! This is a fantastic opportunity to showcase your work and research. Check out the website emn2025.com and submit your abstract by January 12, 2025! Don’t miss out! #MultipleMyeloma #Research Thanos Dimopoulos

#ASH2024 important update on the role of CTCs in myeloma #mmsm by Luca Bertamini Tom Cupedo and EMN! Clearly prognostic in patients treated with the new standard of care and complementary to cytogenetics. Ready for prime time assessment in trials and routine practice

Majestec 4 - safety lead in for Tec or Tec Len maintenance post ASCT. High MRD conversion rates. Key is going to be balancing the toxicity profile with ongoing treatment. #ASH24 mmsm

Let me introduce 📣 ‘Team MRD💯‘ in TE-NDMM #ASH24 #GMMG #DSMM EMN Leo Rasche Elena Zamagni NvdDonk Heidelberg Myeloma

🚨Last few days to submit your abstracts to #EMN2025 conference in Athens! New deadline on January 15, 2025. Check out the website emn2025.com and don't miss out on this opportunity! #MultipleMyeloma #Research Thanos Dimopoulos

✨Registration for the #EMN2025 conference in Athens is now OPEN!🏛️ Don't miss the chance to benefit from the early bird rate - available until April 5! Secure your spot now and join us for an exciting event with #hematologists and #myeloma experts! Thanos Dimopoulos

✨ #EMN2025 has just started in beautiful #Athens!🏛️ Enjoy the conference and interact with speakers! Registration for Meet the Experts parallel sessions is still open.🩺 Don't miss this opportunity! #myeloma #europe #research #clinicaltrials

📢 The new EMN guideline paper on T-cell immunotherapy for #MutlipleMyeloma is now available online in the #LancetHaematology journal! 📰 Thank you Niels van de Donk and Hermann Einsele for leading this important work! Check it out here 👉 thelancet.com/journals/lanha…

📢We are proud to announce that the EHA-EMN guidelines for the diagnosis, treatment and follow-up of #MultipleMyeloma are now available online! Huge thanks to Evangelos Terpos for coordinating such outstanding work! 👉nature.com/articles/s4157… Thanos Dimopoulos European Hematology Association